-transparent.png){kind=logo}
In this double-blind, randomized multicenter study involving 75 patients, the calcium-entry blocker flunarizine (10 mg nocte) was compared with pizotifen (2-3 mg per day in three administrations). Duration of treatment was four months. The results suggest that, in the dosage used, flunarizine is at least as effective as pizotifen in both classical and common migraine as regards effect on attack frequency. Flunarizine might tend to more markedly suppress severity of the attack, though. The weight gain seen with both drugs might be slightly less with flunarizine. A practical advantage of flunarizine is its simple dosage schedule (one intake per day).
Related Publications
P Louis, and
E L Spierings
November 1981,
Headache,
P Louis, and
E L Spierings
February 1986,
Headache,
P Louis, and
E L Spierings
March 1986,
Cephalalgia : an international journal of headache,
P Louis, and
E L Spierings
July 1983,
MMW, Munchener medizinische Wochenschrift,
P Louis, and
E L Spierings
July 1978,
Die Medizinische Welt,
P Louis, and
E L Spierings
May 1985,
Cephalalgia : an international journal of headache,
P Louis, and
E L Spierings
January 1985,
Rivista di neurologia,
P Louis, and
E L Spierings
January 1971,
The New Zealand medical journal,
P Louis, and
E L Spierings
January 1986,
European neurology,
P Louis, and
E L Spierings
September 1988,
Der Nervenarzt,
